Lilly CSO Dan Skovronsky (L) and Andrew Adams, co-director of the Lilly Institute for Genetic Medicine
Q&A: Lilly’s top scientists on genetic medicine ambitions, and how they’re not just for rare diseases
Last week, Eli Lilly opened the doors of its new research center in Boston, largely focused on genetic therapies. While the Indianapolis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
